glp-1 startups management platform What's next for innovation: A primer on the race reshaping pharma and chronic disease care The GLP-1 effect on MedTech – AI, Protein, and GLP-1s: What's

N Engl J Med 326:13161322 Nauck MA, Holst JJ, Willms B, Schmiegel W (1997) Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type 2 diabetes

It has been demonstrated that oral administration of BSH-containing Lactobacillus can reduce serum cholesterol levels in animals and humans, especially Limosilactobacillus fermentum [here we use its new nomenclature according to Naghmouchi et al

Interestingly, these same mutations have been detected in a proportion of benign lichenoid keratosis lesions, suggesting that these lesions represent a common pattern of regression of solar lentigo and seborrheic keratosis (34)

Tobacco mosaic virus

Bednarek J, Wysocki H, Sowinski J

in such settings the risk benefit ratio should be reassessed, and preservative-free preparations considered